Clinical trial
Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis
NCT00407056 · Sirion Therapeutics, Inc., Industry · Completed
Key facts
| NCT number | NCT00407056 |
|---|---|
| Title | Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis |
| Official title | Phase 3 Open-Labeled Study of 0.05% Difluprednate Ophthalmic Emulsion in the Treatment of Severe Anterior Uveitis (Including Panuveitis). |
| Lead sponsor | Sirion Therapeutics, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Uveitis, Panuveitis |
| Intervention type | Drug |
| Interventions | Difluprednate Ophthalmic Emulsion |
| Enrollment | 20 |
| Start date | Aug 1, 2002 |
| Completion | Jun 1, 2003 |
| First posted | Dec 4, 2006 |
| Last update posted | Dec 4, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: